Pear Bio
Pear Bio is a Healthcare & Life Sciences startup based in the United Kingdom, most recent round Series A, 1 tracked investor.
About Pear Bio
Pear Bio is a company headquartered in the United Kingdom. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Pear Bio is a computational biology company that has developed a functional precision medicine platform to optimize clinical cancer care and drug development. The platform uses microphysiological systems and 3D computer vision to measure cancer progression over time by culturing patient tumor samples and immune cells to test potential treatment options and combinations ex vivo.
Explore Pear Bio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.